Barbie's first doll with Type 1 diabetes comes complete with accurate glucose monitor, insulin pump
Mattel announced the release of the first-ever Barbie doll with type 1 diabetes, complete with a continuous glucose monitor and an insulin pump in Barbie's signature pink.
a
5 Mattel released the first Barbie with type 1 diabetes.
Mattel
'Introducing a Barbie doll with type 1 diabetes marks an important step in our commitment to inclusivity and representation,' Krista Berger, Senior Vice President of Barbie and Global Head of Dolls, said in a statement.
'Barbie helps shape children's early perceptions of the world, and by reflecting medical conditions like T1D, we ensure more kids can see themselves in the stories they imagine and the dolls they love.'
5 The new doll is part of the brand's inclusive Fashionistas line, which allows more children to see themselves reflected in Barbie and encourages a view beyond their lived experience.
Mattel
Mattel partnered with Breakthrough T1D, the leading global type 1 diabetes research and advocacy organization, to ensure that the doll accurately captured the community and to accurately depict the medical equipment those with the condition may use.
On her arm, the new doll wears a continuous glucose monitor to help manage her type 1 diabetes, held in place with pink heart-shaped medical tape. It also comes with a Barbie phone that displays a CGM app to help track her blood sugar levels — just like the real-life monitors, which track glucose levels 24 hours a day via a sensor under the skin.
Barbie also has an insulin pump attached to her waist that can automatically administer insulin as needed.
5 The color blue and circle print are both nods to global symbols that represent diabetes awareness.
MATTEL/AFP via Getty Images
Mattel even worked with Breakthrough T1D to determine the dress pattern. She wears a blue polka dot top and matching skirt, and the color blue and circle print are both nods to global symbols that represent diabetes awareness.
Of course, the new Barbie also has a purse to carry any essentials on the go, such as type 1 diabetes supplies or snacks.
'It means the world to be part of bringing greater visibility to a condition that affects so many families,' Aaron J. Kowalski, Ph.D., CEO of Breakthrough T1D, said in a statement.
'It's an honor to work with a brand that shares our commitment to showing children that a life with type 1 diabetes can be full, vibrant, and empowering.'
5 Barbie has an insulin pump attached to her waist.
Mattel
In coordination with the release of the new Barbie with type 1 diabetes, Barbie also honored two global type 1 diabetes advocates, Peloton Instructor Robin Arzón in the US and model Lila Moss in the UK, with their own one-of-a-kind Barbie dolls.
'To be able to now see Barbie dolls with T1D, and to receive a Barbie doll that visibly looks like me even wearing her patches, is both surreal and special,' Moss said.
'It's an absolute honor to receive a Barbie doll as a part of the brand's efforts to grow awareness and representation surrounding type 1 diabetes, so that we can help show kids that all types of challenges give us all the more reason to push forward and achieve our dreams,' Arzón added.
5 On her arm, the new doll wears a continuous glucose monitor to help manage her type 1 diabetes.
Mattel
Type 1 diabetes is a chronic autoimmune condition that causes the pancreas to make little or no insulin, a hormone that allows sugar (glucose) to enter cells to produce energy, ultimately leading to dependence on insulin therapy.
Approximately 1.24 million people in the US live with type 1 diabetes, and that number is expected to grow to 5 million by 2050.
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
3 days ago
- Yahoo
Plastic Surgeons Revealed Which Procedures Are So Dangerous They'd Never Get Themselves, And I'm Stunned
I'm all for plastic surgery and cosmetic procedures. Listen, if it makes you feel good in your own skin, then that in itself is a huge win. But some procedures, while they may make you look nice, might actually do more harm than good. A while back, Reddit user Topgunner85 asked, "Plastic surgeons of Reddit, what body-altering surgery would you never get and why?" 1."Iris depigmentation laser surgery. The risks of blindness or complications are quite high. And it looks bad." —Littman-Express "I work with ophthalmologists (this would be oculoplastics) and ALL of them pretty much say the same thing. The procedure is dumb and 9/10 causes blindness due to induced glaucoma from the pigment." —letsxxdiscooo 2."My husband is an ICU nurse and sees men with penile implant infections all the time. He says the guys (and their S.O.'s) regret them in later years since they're in and out of the hospital all the time." —HappyBirthdayYall Related: 3."Honestly? Rib removal surgery — just to get a smaller waist or 'Barbie' silhouette. As someone who's been around medical tourism and seen both great and terrible results, I've noticed that anything messing with internal structure like that is playing with fire. It's not just about aesthetics — your ribs protect your organs. Removing them is risky, painful, and recovery can be brutal. I've seen people fly across the world for cheap procedures like this, only to end up with nerve damage or breathing problems." "Some surgeries just aren't worth the risk, no matter how good the photos look online." —abdalkadermj 4."As a nurse who has worked extremely closely with plastics, I would say BBL (Brazilian butt lift), 100%. From blood clots to sepsis, it's just not worth it. If the fat travels into the bloodstream, it's over. Not worth the risks." —No_Bullfrog3950 5."Buccal fat removal makes you look like a skeleton when you age and the rest of your fat goes away." —patpadelle 6."I would never get a 'nonsurgical' or 'liquid' rhinoplasty. Most of the time, that's just filler injected into the nose. There is a risk of filler in this location causing you to go blind." —boyyousaidit 7."Former surgical technician here, and the surgery I would NEVER get is interocular contacts. Had a patient who went to Turkey to have it done. They came back looking like something from a horror movie. They were in so much pain, all they could do was cry. When we removed the first one, you could feel the relief leaving their body. They had to wait two weeks to do the other eye. Leave your eyes alone!!!!!! Just wear GLASSES 🤓!" —comfydaredevil795 Related: 8."Leg lengthening surgery. Because this is one of the most traumatic and painful operations, with long recovery, risks of complications, and all for the sake of aesthetic or social conformity. The operation involves a bone fracture, its stretching with the help of devices, and months — or even years — of pain and rehabilitation. At the same time, the result may be unstable, and expectations may be inflated. For me, it would be too high a price for trying to meet external standards. I'd rather work on accepting myself and finding an environment where growth doesn't matter." —Turbulent-Net-4927 9."Laryngoplasty. I have a few LGBTQ+ friends who have taken most of the steps to physically transition from male to female (breast implants, vaginal augmentation, hormone therapy, etc). I found out that most will not attempt to surgically alter their voice, as it is a very dangerous procedure." —groovytoon 10."One thing I've heard a lot — especially from people in their 30s and 40s — is that bone-cutting surgeries (like jaw or cheekbone reduction) are the ones they regret most later. Many say it affects aging, nerve sensitivity, and causes long-term discomfort." —Individual-String-18 Related: 11."Hair implants. The implants are definitely visible, the donor area always gets rare, and if you don't take finasteride (a drug that has impotence as a possible side effect), the hair between the plugs WILL fall. It may be a good procedure for some, and I know many people who are happy with the results, but I'd rather keep my penis functioning than my hair. And yes, I know, not everyone gets those side effects. But many do, and in some cases, they are permanent." —sinutzu 12."In general, I would never get any facial fillers. They tend to look worse over time and migrate." —boyyousaidit 13."I recently saw a post about 'hunter eye' surgery that had gone wrong and looked terrible. Basically, it's trending with men who want to have smaller eyes that slant upwards so they look like hunters and not prey. So, they're getting this surgery to alter the slant of their eyes AND DECREASE THE VOLUME OF THEIR EYEBALLS to get smaller eyes. It's exactly as horrific as it sounds, and there are some incredibly questionable results from it. Some of them looked okay after, but it's a wild reason to let someone suck the juice from your eyeballs, slice through the conjunctiva, slice through the outer corner of the eye, and remove a portion of the eye socket." —binglybleep 14."Botox is used to treat spastic muscles in cerebral palsy, but as someone who already looks way younger than 31, why would you risk your life when you could just look your age?" —daynam4b6e28fa3 "It is a little hard to see your face age — I get it. Not everyone has enough self-esteem or good sense to let themselves age without intervention. If you're gonna put money into preventing aging, do less risky procedures. Red light therapy, lasers, microneedling…there are definitely alternatives." —putzik47 15."I'm a nurse, but I'll say liposuction. It's horrible on the body with a high risk of infection, bleeding, and embolism. You get better results with diet and exercise." —mid_1990s_death_doom 16."360 lifts and abdominoplasty (tummy tuck), basically anything that involves removing large amounts of skin and tissue. It's even worse if they combine it with liposuction. I gave this answer because I think the complications are serious enough to warrant very careful consideration from people that do need it. Just because a surgery can improve a person's quality of life doesn't mean we should ignore the potential risks." —SquilliamFancySon95 Related: 17."I'd never get tongue splitting — it's permanent, can mess with speech, and just isn't worth the risk. I'd rather not gamble with how I talk or eat." —chiefecon 18."I'd stay away from anything that involves going to another country to get something at a discount. One of the issues with surgery, any surgery, is that they often have complications. Good luck finding a surgeon to touch you when it isn't his/her work, let alone it being done at some shady center outside the country. You could either find yourself paying insanity level money for correction, or simply live as whatever monster a shady butcher leaves you as." —Dr_Esquire finally, "A DIEP flap for breast reconstruction. It's a much bigger surgery than they expect, and it's got such a difficult recovery that takes so long. My patients who opt for the tissue expander to implant instead have a much easier recovery." —inquisitor_korath Responses have been edited for length/clarity. To all the plastic surgeons, nurses, and practitioners out there, which body-altering procedures would you NEVER get, and why? Let us know in the comments, or if you prefer to stay anonymous, tell us your story in the form below. Also in Goodful: Also in Goodful: Also in Goodful:
Medscape
12-08-2025
- Medscape
Diabetes Tech Use On the Rise But A1c Reductions Still Lag
Use of diabetes technology has dramatically increased and glycemic control has improved among people with type 1 diabetes (T1D) in the US over the past 15 years, but at the same time, overall achievement of an A1c level < 7% remains low and socioeconomic and racial disparities have widened. These findings came from an analysis of national electronic health records of nearly 200,000 children and adults with T1D by Michael Fang, PhD, of the Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health, Baltimore, and colleagues. The study was published online on August 11, 2025, in JAMA Network Open . Use of continuous glucose monitors (CGMs) increased substantially from 2009-2011 to 2021-2023, from less than 5% in both children and adults to more than 80% and over half, respectively. While A1c levels did drop over the 15 years, just 1 in 5 children and slightly over a quarter of adults achieved a level < 7%. The average A1c level stayed above 8%, with ethnic minorities and low-income patients seeing the smallest gains. 'Additional opportunities for individualized patient and clinician education can help optimize the use of technologies. In our analyses, the increase in CGM and insulin pump use substantially outpaced gains in glycemic control,' Fang and colleagues wrote. In an accompanying editorial, Diana Soliman, MD, of the Division of Endocrinology at the University of Miami Miller School of Medicine in Miami, and colleagues wrote, 'As technological innovation continues to accelerate, it is encouraging to see signs of progress in glycemic management. Ensuring that these advances benefit all individuals with T1D must remain a priority.' Asked to comment, Anne L. Peters, MD, professor of clinical medicine and director of Clinical Diabetes Programs at the Keck School of Medicine of USC, Los Angeles, told Medscape Medical News that a key component is having staff to help with prior authorization paperwork and certified diabetes care and education specialists (CDCES) to help train patients and troubleshoot. 'These health disparities are real but fixable. However, it takes staff to make it happen.' Tech Use On the Rise But A1c Level Hasn't Dropped Much Fang and colleagues used the OptumLabs Data Warehouse to identify 186,590 eligible individuals with T1D, of whom 26,853 were younger than 18 years. Three quarters were White, 12% were Black, and 7% were Hispanic individuals. Few previous studies of T1D have included such representative population-based data, the authors noted. From 2009-2011 to 2021-2023, among youths, the use of CGMs rose from 4% to 82%, insulin pumps from 16% to 50%, and the combination from 1% to 47% ( P for trend < .001 for all). Such use in 2021-2023 was higher among White youths and those with commercial insurance. During the same period, among adults, the use of CGM rose from 5% to 57%, insulin pumps from 11% to 29%, and the combination from 1% to 22% ( P for trend < .001 for all). Throughout, adults who were White, younger, and commercially insured were more likely to use CGMs. Overall, mean A1c levels dropped from 8.9% to 8.3% in youths and from 8.2% to 8.0% in adults from 2009-2011 to 2021-2023. Among youths, the prevalence of achieving glycemic control, defined as an A1c level < 7%, rose from about 7% in 2009-2011 and 2014-2017 to 19% in 2021-2023 ( P for trend < .001). Glycemic control improved for all youth subgroups except for Black youths. Differences by race, ethnicity, and insurance type increased after 2018-2020. During 2021-2023, 21% of White youths vs 17% of Hispanic and 12% of Black youths achieved glycemic control. Those with commercial health insurance also had higher rates of glycemic control than those with Medicaid insurance (22% vs 13%). For adults with T1D, glycemic control rose from 21% in 2009-2011 to 28% in 2021-2023 ( P for trend < .001). Again, the prevalence of achieving glycemic control was higher among those who were White (30% vs 20% of Hispanic and 21% of Black patients in 2021-2023) and those who had commercial insurance (30% vs 19% of those who had Medicaid insurance). Implications for Clinical Practice These findings have important implications for clinical practice and policy, Soliman and colleagues said. 'Barriers to diabetes technology access, including financial costs, lack of clinician prescription, and inadequate clinical communication, continue to disproportionately affect medically underserved populations. While the increase in diabetes technology may be attributed to expanded insurance coverage, incorporation into guidelines, and improved technology, there remains a crucial need to extend this technology more widely.' Addressing these challenges, they said, 'requires coordinated efforts that combine reduced financial barriers with clinician training, shared decision-making, and culturally competent communication to promote equitable and effective use of technology.' Peters has one practice in the relatively wealthy west side of Los Angeles and another in an underserved area in East Los Angeles. On the west side, she has a full-time staffer who exclusively handles prior authorizations for diabetes devices and a CDCES who trains patients and follows them weekly. The patients there all speak English and have high health literacy. On the east side, there aren't any educators and no classes on advanced technology. A prescription for an automated insulin delivery device can take months to get filled. Non-English speaking patients may have difficulty accessing manufacturer assistance and may lack smartphones compatible with their devices. Even when patients are able to start using the technology, they may not have the support they need to continue. 'The systems of care often lack what it takes to provide adequate care for under-resourced people with T1D. When we've had research funding to provide a CDCES, my patients in East LA do great. The training often takes longer than in those who are starting at a higher knowledge level, but technology is very useable by under-resourced people,' Peters said. The study was funded by the National Heart, Lung, and Blood Institute and the National Institute of Diabetes and Digestive and Kidney Diseases. Fang had no other disclosures. Soliman had no disclosures. Peters reported recording videos for Medscape Medical News, being on the advisory board for Vertex, and having stock options for Omada Health.
Medscape
05-08-2025
- Medscape
Meet Barbie's Secret Weapon Against Type 1 Diabetes
Mattel, the US-based company behind the Barbie brand, launched its first Barbie doll designed with features of type 1 diabetes ( T1D). 'Introducing a Barbie doll with T1D marks an important step in our commitment to inclusivity and representation,' said Krista Berger, senior vice president of Barbie and global head of Dolls. 'Barbie helps shape children's early perceptions of the world, and by reflecting medical conditions like T1D, we ensure more kids can see themselves in the stories they imagine and the dolls they love.' Rising Numbers T1D is a chronic autoimmune condition that affects millions of individuals, including children and adolescents, worldwide. To ensure that the new Barbie doll accurately represents the lived experience of individuals managing this condition, Mattel partnered with Aide aux Jeunes Diabétiques, a French charity that supports young people with diabetes, and Breakthrough T1D (formerly JDRF), a global organisation focused on research, advocacy, and improving care for people with T1D. These collaborations helped ensure that the doll's features, including the use of real-world medical devices such as a continuous glucose monitor and insulin pump, reflected the current standards in diabetes management. The aim was to promote inclusion and awareness by representing the everyday reality of children with T1D. The new Barbie doll features: Continuous glucose monitor: The doll wears a continuous glucose monitor on her arm to support blood glucose management in T1D. These small, wearable devices measure glucose levels continuously throughout the day. The sensor is secured with heart-shaped medical tape in Barbie pink, and the doll includes a phone that displays a monitoring app used to track glucose levels in real time. The doll wears a continuous glucose monitor on her arm to support blood glucose management in T1D. These small, wearable devices measure glucose levels continuously throughout the day. The sensor is secured with heart-shaped medical tape in Barbie pink, and the doll includes a phone that displays a monitoring app used to track glucose levels in real time. Insulin pump: Attached at her waist, the insulin pump is a small wearable device that delivers insulin automatically, as needed. This method of insulin administration is widely used by individuals with T1D to maintain stable blood glucose levels. Attached at her waist, the insulin pump is a small wearable device that delivers insulin automatically, as needed. This method of insulin administration is widely used by individuals with T1D to maintain stable blood glucose levels. Blue polka dot outfit: The doll wears a polka dot top and matching ruffled skirt. Both the blue colour and circular print are recognised global symbols for diabetes awareness, including the blue circle associated with World Diabetes Day. The doll wears a polka dot top and matching ruffled skirt. Both the blue colour and circular print are recognised global symbols for diabetes awareness, including the blue circle associated with World Diabetes Day. Pastel blue handbag: The doll carries a pastel blue handbag intended for essential items, such as diabetes supplies or snacks. This detail reflects the everyday practical needs of individuals managing T1D, including the need to prevent or treat hypoglycaemia when away from home. Ambassadors To launch its Barbie doll featuring T1D, Mattel chose the French karate champion, Alizée Agier, as ambassador. Agier won the world championship in 2014 and European titles in 2019 and 2024. She was diagnosed with T1D at the age of 19 years and has since become a strong advocate for awareness and inclusion. 'It's not diabetes that defines me, but what I do with it. As the campaign's ambassador, she inspires thousands of young people — whether ill or not — to believe in their potential,' Agier said. Mattel also honoured two global role models and T1D advocates: Peloton instructor Robin Arzón in the US and model Lila Moss in the UK with personalised Barbie dolls. Arzón is known internationally for her work as a fitness leader and author, while Moss is a fashion model and daughter of the British supermodel Kate Moss. Both women live with T1D and use their public platforms to raise awareness and improve visibility of the condition. Arzón presented a new Barbie doll with T1D, along with her custom Barbie doll, during an event at Peloton Studios in New York City. Members of the T1D community welcomed the event as a positive step towards inclusion. 'After being diagnosed with T1D a decade ago, I've found a lot of purpose in advocating for people with the condition and educating others about it because knowledge is power — especially for young minds,' said Arzón. 'It's an absolute honour to receive a Barbie doll as a part of the brand's efforts to grow awareness and representation surrounding T1D so that we can help show kids that all types of challenges give us all the more reason to push forward and achieve our dreams.' Moss said, 'I am proud to use my platform to educate around T1D and show that being different is cool. Receiving messages from people who see my patches and feel represented means everything to me. To be able to now see Barbie dolls with T1D, and to receive a Barbie doll that visibly looks like me, even wearing her patches, is both surreal and special.' The Barbie Fashionistas line now includes more than 175 dolls, offering a wide range of skin tones, eye colours, hair textures, body types, fashion styles, and medical conditions. The collection featured dolls with visual impairment, dolls with Down syndrome, and dolls with hearing aids. In 2020, Barbie began a multiyear research collaboration with Cardiff University to explore how doll play supports children's development. According to the company, early findings suggest that playing with dolls may help children develop empathy, build social skills, and imagine a future in which everyone has equal opportunities. Details are reported on the Mattel corporate website.
